Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMS-741672 in Diabetic Neuropathic Pain
NCT00683423Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Jul 2008
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in diabetic neuropathy comparing BMS-741672 with Placebo (2 arms). Primary endpoint: Reduction in weekly average pain score. Started Jul 2008; status: completed.
02
Drugs
BMS-741672
03
Conditions
diabetic neuropathy
Beyond the preview
Go deeper on NCT00683423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00683423.